Navigation Links
Watson Confirms Filing of Generic Opana(R) ER Application
Date:3/8/2010

Forward-Looking Statement

Statements contained in this press release that refer to Watson's estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release.  For instance, any statements in this press release concerning prospects related to Watson's product introductions and anticipated financial performance are forward-looking statements.  It is important to note that Watson's goals and expectations are not predictions of actual performance.  Watson's performance, at times, will differ from its goals and expectations.  Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business.  These factors include, among others, the inherent uncertainty associated with financial projections; the impact of competitive products and pricing; the difficulty of predicting the timing or outcome of litigation; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; and such o
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson Signs Agreement to Divest Equity Interest in ScinoPharm
2. Watson to Present at CLSA/Asia USA Investors Forum
3. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
4. Watson Completes Acquisition of Eden Biodesign
5. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
6. Watson Files FDA Application for Generic Rozerem(R)
7. Watson to Present at Credit Suisse Healthcare Conference
8. Watson and Barr Settle Lawsuit Over Oxytrol(R)
9. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
10. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
11. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
(Date:9/3/2015)... , Sept. 3, 2015 This Defibrillators ... to save millions of lives across globe. This report ... Kingdom of Saudi Arabia . Stakeholders for ... suppliers, government agencies and regulatory bodies. The ... from two perspectives: by products and by end users. ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
Breaking Medicine Technology:IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
(Date:9/3/2015)... TX (PRWEB) , ... September 03, 2015 , ... ... pre-conference workshops included in Patient Experience Conference 2016, to be held April 13-15 ... non-provider or vendor hosted event bringing together the collective voices of healthcare leaders, ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a ... partnered with Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for ... with DriButts plans to bring 600 DriButts Diapers to rural areas of Haiti ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Real Time ... today announced that professional bull rider David Mason has signed an official endorsement deal ... at the age of six and his first bull at 15. He is an ...
(Date:9/3/2015)... FL (PRWEB) , ... September 03, 2015 , ... ... the Florida Companies to Watch for 2015 by economic development group ... of only 50 companies in the state selected for this prestigious award, which ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... investment landscape by connecting accredited and institutional investors to real estate investment opportunities ... designed to meet demand from both investors and sponsoring real estate companies. ...
Breaking Medicine News(10 mins):Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... Researchers at the University of Rochester when investigating for ... treated hot flashes as good as estrogen. ... the flow of calcium in and out of the ... ,flow risks like was researchers, who have been investigating ...
... making it mandatory for food manufacturers to add folate to ... organisation that monitors food standards in New Zealand is to ... ,Many live births and stillbirths each year ... as spina bifida, where one or more vertebrae fails to ...
... send to Australia for radiation therapy if the waiting ... oncology said, he has talked to Capital and Coast ... outside for treatment, either within New Zealand or to ... time for Wellington cancer patients, which has grown to ...
... a sigh of relief following the nod of approval ... the world’s first anti-AIDS cocktail drug for use as ... bulk drugs major Aurobindo Pharma, has made combined anti-retro ... (nevirapine) into a single three-in-one fixed dose drug. ...
... with greater determination from obscurity to a global emergency, the ... outpacing us, or are countries acting too slowly to address ... another 40 million worldwide? ,In early June, when ... meeting to the United Nations General Assembly's Special Session on ...
... India Institute of Medical Sciences has requested President A ... of reservation// and end to 'victimisation' of reserved category ... to the gherao of the sub-dean of the institute, ... President to exercise his moral authority and ask the ...
Cached Medicine News:Health News:Gabapentin Reduced Menopausal Symptoms as Estrogen – Study Find 2Health News:NZ To Opt For Folate Fortification Of Bread 2Health News:AIDS: Why the pandemic outpaces us 2Health News:AIDS: Why the pandemic outpaces us 3
... typical patient, right for the not-so-typical patient., ... the ability to address the atypical situations ... themeven after implant. St. Jude Medical ICDs ... prepared in almost any situation, from high ...
... 105SL combines enhanced memory, processing ... and reliable all-metal construction. Proven ... and print speed make it ... who value reliability, productivity, consistent ...
... Built on the solid, tested ... six-inch labels --offers an unprecedented level ... placement as well as unique features ... into enterprise systems, automatic calibration, flexible ...
... The 220XiIII quickly prints labels ... at 10 ips. It is ... such as printing chemical drum ... automotive industry labels, banner-sized labels ...
Medicine Products: